Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Cancer Cell
|
July 9, 2010
All roads lead to the ribosome
Steven Whittaker, Matthew Martin, Richard Marais
Cancer Cell
|
March 14, 2007
The EGF receptor Hokey-Cokey
Dan Niculescu-Duvaz, Steven Whittaker, Caroline Springer, et al.
Journal of Biomolecular Screening
|
December 20, 2005
Identification of inhibitors of the kinase activity of oncogenic V600E BRAF in an enzyme cascade high-throughput screen
Yvette Newbatt, Samantha Burns, Robert Hayward, et al.
Science Translational Medicine
|
June 12, 2010
Gatekeeper mutations mediate resistance to BRAF-targeted therapies
Steven Whittaker, Ruth Kirk, Robert Hayward, et al.
Bioorganic & Medicinal Chemistry
|
February 5, 2013
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents
Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Cell
|
February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
Sonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
Cancer Research
|
September 3, 2010
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF
Steven Whittaker, Delphine Ménard, Ruth Kirk, et al.
Journal of Medicinal Chemistry
|
February 13, 2010
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring
Arnaud Nourry, Alfonso Zambon, Lawrence Davies, et al.
Journal of Medicinal Chemistry
|
July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors
Alfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
Stuart C Wilson, Butrus Atrash, Clare Barlow, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Cancer Cell
|
July 9, 2010
All roads lead to the ribosome
Steven Whittaker, Matthew Martin, Richard Marais
Cancer Cell
|
March 14, 2007
The EGF receptor Hokey-Cokey
Dan Niculescu-Duvaz, Steven Whittaker, Caroline Springer, et al.
Journal of Biomolecular Screening
|
December 20, 2005
Identification of inhibitors of the kinase activity of oncogenic V600E BRAF in an enzyme cascade high-throughput screen
Yvette Newbatt, Samantha Burns, Robert Hayward, et al.
Science Translational Medicine
|
June 12, 2010
Gatekeeper mutations mediate resistance to BRAF-targeted therapies
Steven Whittaker, Ruth Kirk, Robert Hayward, et al.
Bioorganic & Medicinal Chemistry
|
February 5, 2013
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents
Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Cell
|
February 10, 2010
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
Sonja J Heidorn, Carla Milagre, Steven Whittaker, et al.
Cancer Research
|
September 3, 2010
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF
Steven Whittaker, Delphine Ménard, Ruth Kirk, et al.
Journal of Medicinal Chemistry
|
February 13, 2010
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring
Arnaud Nourry, Alfonso Zambon, Lawrence Davies, et al.
Journal of Medicinal Chemistry
|
July 6, 2010
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors
Alfonso Zambon, Delphine Ménard, Bart M J M Suijkerbuijk, et al.
Bioorganic & Medicinal Chemistry
|
October 11, 2011
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
Stuart C Wilson, Butrus Atrash, Clare Barlow, et al.
Page
of 2